Everything about Metronidazole totally explained
,,,
| PubChem=4173
| DrugBank=APRD00631
| C=6|H=9|N=3|O=3
| molecular_weight = 171.15 g/mol
| bioavailability = 100% (oral)
59–94% (rectal)
| metabolism =
Hepatic
| elimination_half-life = 6–7 hours
| excretion =
Renal (60-80%),
biliary (6–15%)
| pregnancy_category = B2
(Au)
| legal_AU = S4
| legal_UK = POM
| routes_of_administration = Oral,
topical,
rectal,
IV,
vaginal
}}
Metronidazole (
INN) is a
nitroimidazole [[antiinfective] medication used mainly in the treatment of infections caused by susceptible organisms, particularly
anaerobic bacteria and
protozoa. It is marketed by
Pfizer under the trade name
Flagyl in the US, while
Sanofi-Aventis markets metronidazole globally under the same tradename,
Flagyl, and also by various generic manufacturers, who sell it at a lower price.
Metronidazole is also used as a gel preparation in the treatment of the
dermatological conditions such as
rosacea (
Rozex and
MetroGel by
Galderma) and
fungating tumours (
Anabact, Cambridge Healthcare Supplies).
Metronidazole is a
prodrug. It is converted in
anaerobic organisms by the
redox enzyme pyruvate-
ferredoxin oxidoreductase. The nitro group of metronidazole is chemically reduced by ferredoxin (or a ferredoxin-linked metabolic process) and the products are responsible for disrupting the
DNA helical structure, thus inhibiting
nucleic acid synthesis.
Metronidazole is selectively taken up by
anaerobic bacteria and sensitive
protozoal organisms because of the ability of these organisms to reduce metronidazole to its active form intracellularly.
Indications
Systemic metronidazole is indicated for the treatment of:
- Vaginitis due to Trichomonas vaginalis (protozoal) infection in both symptomatic patients as well as their asymptomatic sexual contacts
- Bacterial vaginosis, commonly associated with overgrowth of Gardnerella species, in symptomatic patients
- Pelvic inflammatory disease in conjunction with other antibiotics such as ofloxacin, levofloxacin, or ceftriaxone
- Protozoal infections due to Entamoeba histolytica (Amoebic dysentery or Hepatic abscesses), and Giardia lamblia (Giardiasis) should be treated alone or in conjunction with iodoquinol or diloxanide furoate
- Anaerobic bacterial infections such as Bacteroides fragilis, spp, Fusobacterium spp, Clostridium spp, Peptostreptococcus spp, Prevotella spp, or any other anaerobes in intraabdominal abscess, peritonitis, empyema, pneumonia, aspiration pneumonia, lung abscess, diabetic foot ulcer, meningitis and brain abscess, bone and joint infections, septicemia, endometritis, tubo-ovarian abscess, or endocarditis
- Pseudomembranous colitis due to Clostridium difficile
- Helicobacter pylori eradication therapy, as part of a multi-drug regimen in peptic ulcer disease
- Prophylaxis for those undergoing potentially contaminated colorectal surgery and may be combined with neomycin
- Acute gingivitis and other dental infections (TGA approved, non-Food and Drug Administration (FDA) approved)
- Crohn's disease with colonic or perianal involvement (non-FDA approved)- believed to be more effective in combination with ciprofloxacin
- With amphotericin B and certain other drugs, it's used as an adjunct in the attempted treatment of primary amoebic meningoencephalitis caused by Naegleria fowleri infection
Topical metronidazole is indicated for the treatment of
rosacea, and in the treatment of malodorous
fungating wounds.
Prevention of preterm births
Metronidazole has also been used in women to prevent preterm birth associated with
bacterial vaginosis, amongst other risk factors including the presence of cervicovaginal fetal fibronectin (fFN). A
randomised controlled trial demonstrated that metronidazole was ineffective in preventing preterm delivery in high-risk pregnant women and, conversely, the incidence of preterm delivery was actually higher in women treated with metronidazole.
Lamont has argued that Metronidazole isn't the right antibiotic to administer in these circumstances and was often administered too late to be of use.
Clindamycin administered early in the second trimester to women who test positive for
bacterial vaginosis seems to be more effective.
Adverse effects
Common
adverse drug reactions (≥1% of patients) associated with
systemic metronidazole therapy include:
nausea,
diarrhea, and/or metallic taste in the mouth.
Intravenous administration is commonly associated with
thrombophlebitis. Infrequent adverse effects include:
hypersensitivity reactions (rash, itch, flushing, fever), headache, dizziness,
vomiting,
glossitis,
stomatitis, dark urine, and/or
paraesthesia. Nevertheless, it appears to have a fairly low potential for cancer risk and under most circumstances the benefits of treatment outweigh the risk.
Common adverse drug reactions associated with topical metronidazole therapy include local redness, dryness, and/or skin irritation; and eye watering (if applied near eyes). Consumption of alcohol should be avoided by patients during systemic metronidazole therapy and for at least 24 hours after completion of treatment. and a possible central toxic serotonin reaction for the alcohol intolerance suggested.
Further Information
Get more info on 'Metronidazole'.
|
External Link Exchanges
Do you know how hard it is to get a link from a large encyclopaedia? Well we're different and will prove it. To get a link from us just add the following HTML to your site on a relevant page:
<a href="http://metronidazole.totallyexplained.com">Metronidazole Totally Explained</a>
Then simply click through this link from your web page. Our crawlers will verify your link, extract the title of your web page and instantly add a link back to it. If you like you can remove the words Totally Explained and embed the link in article text.
As long as your link remains in place, we'll keep our link to you right here. Please play fair - our crawlers are watching. Your site must be closely related to this one's topic. Any kind of spamming, dubious practises or removing the link will result in your link from us being dropped and, potentially, your whole site being banned. |